Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niaoduqing Particles for progression delay in stage 3-4 chronic kidney disease
ChiCTR-TRC-12002448Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 1990
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of niaoduqing in chronic kidney disease (CKD) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Serum creatinine, Estimated glomerular filtration rate and 1 more. Started Jan 1990; status: completed.
02
Drugs
niaoduqing
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR-TRC-12002448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002448.